Introduction
Enrollment in HIV clinical care at advanced stage of disease (late enrollment in care) denotes critical missed opportunities to improve the health and well being of HIV-positive people [1] [2] [3] , and limits the potential of treatment at earlier stages of HIV disease to reduce HIV transmission [4] and potentially attenuate incidence [5] [6] [7] . Most studies of the prevalence, correlates, and outcomes of late enrollment in HIV care have been conducted in Europe and North America [1, 2, [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] . In sub-Saharan Africa, studies have largely focused on advanced disease at antiretroviral therapy (ART) initiation [19] [20] [21] . Far less is known about advanced disease at enrollment in HIV care, a critical precursor to late ART initiation in this region [22] . In particular, whether the prevalence of late enrollment has changed over time with scale-up of care and treatment in sub-Saharan Africa is unknown. Additionally, multiple barriers to early diagnosis and prompt linkage to care likely exist in sub-Saharan Africa, but with few exceptions [23] [24] [25] only individual-level correlates have been examined. Characteristics of the HIV care facility and features of the broader social environment in which a facility operates [21, 26] may also influence timing of enrollment in HIV care.
Advanced HIV disease has frequently been defined as a CD4 þ cell count 200 cells/ml or less, or even lower (e.g. [15, 17, 25] ). In 2010, the WHO released expanded criteria for ART eligibility in low and middle-income countries, recommending ART initiation for persons with CD4 þ cell count below 350 cells/ml or WHO stage 3 or 4 [27] . In this study, we defined late enrollment in care based on the WHO 2010 treatment guidelines, in order to describe progress toward meeting the goal of universal access to treatment. Specifically, we examined changes between 2006 and 2011 in the proportion of HIV-positive patients who enrolled late in HIV care and in the median CD4 þ cell count at enrollment; and identified individual, program, and contextual-level factors associated with late enrollment in care in 2011.
Methods

Study population
The study population included HIV-positive adults aged 15-85 years newly enrolling in HIV care between 1 January 2006 and 31 December 2011 at 138 HIV care facilities that provided continuous services during this time period in four sub-Saharan African countries: Kenya (64 facilities), Mozambique (29) , Rwanda (24) , and Tanzania (21) . An additional 57 facilities providing services in 2011 were included in the analysis of correlates of late enrollment in 2011 (N ¼ 195) . All programs were receiving technical support from ICAP at Columbia University through funding from the United States President's Emergency Plan for AIDS Relief (PEPFAR). Provision of services at each facility was conducted according to national guidelines, with all providing both pre-ART and ART services. These facilities had implemented electronic databases to manage patient information routinely collected during each visit; when compared to all facilities supported by ICAP in those same countries during the study period, the facilities included in this analysis had higher patient volume, and were more likely to be located in urban areas and to be higher-level facilities (data not shown).
For this study, we included patients if CD4 þ cell count or WHO clinical staging information were available up to 3 months after enrollment in HIV care, given that CD4 þ cell counts are not always performed immediately at enrollment. Additionally, patients who were missing both CD4 þ cell count and clinical stage were included if they initiated ART within 1 month of enrollment, as these patients enrolled late and likely were initiated on ART without documentation of CD4 þ cell count or clinical stage.
Data sources
Patient information routinely collected during each clinic visit was documented by clinicians on national patient forms. This information was regularly entered into on-site electronic databases by data clerks. Data quality assessments were conducted at least annually at each facility using a standardized protocol. This entailed drawing a random sample of approximately 5-20% (depending on total patient volume) and assessing completeness and accuracy of key data elements. Remediation plans were developed for sites with poor-data quality (<80% completeness and accuracy) and data quality was re-assessed after their implementation. Each quarter, data were de-identified at the site-level, encrypted, and imported into a commonformat database. Use of these de-identified patient-level data for research purposes was approved by National Ethics Committees in each country, the Columbia University Medical Center Institutional Review Board, the United States Centers for Disease Control and Prevention, and the PEPFAR Office of the Global AIDS Coordinator (OGAC).
Data on facility characteristics were derived from structured assessments completed by ICAP staff incountry in August 2011. The assessment comprised 85 closed-ended questions about the types of HIV-related services provided at the facility and the characteristics of the HIV program (e.g. staffing configurations, availability of supportive services). Administration of this assessment was considered nonhuman patient research because data referred to facilities, not to individuals.
Contextual-level data were obtained from national census and from country-specific, population-based surveys, namely the Demographic and Health Surveys and AIDS Indicator Surveys, using the most recently completed survey -2008 for Kenya, 2009 for Rwanda, and 2011 for Tanzania and Mozambique. For Kenya and Rwanda, 2011 estimates for contextual-level variables were imputed by extending the slope between the most recently available data and that from the previous time point.
Measures
The main study outcome, derived from the routinely collected patient data, was enrollment in HIV care with advanced HIV disease, or late enrollment in care. Late enrollment in care was defined as having CD4 þ cell count 350 cells/ml or less and/or WHO clinical stage 3/4 documented within 3 months of enrollment. In addition, those who were missing these parameters were considered to have enrolled in care late if they initiated ARTwithin 1 month of enrollment in care.
Predictors were selected based on our conceptual framework, including factors that might influence late testing or delayed enrollment after diagnosis [22] . Individual-level variables examined included age, sex, pregnancy status, marital status, and point of entry into care. The latter was categorized as voluntary counseling and testing (VCT) service, prevention of mother-to-child transmission (PMTCT) program, or provider-initiated testing and counseling (PITC) [including HIV testing among inpatients or outpatients in the general outpatient department, family planning clinic, tuberculosis (TB) clinic, or sexually transmitted infection (STI) clinic, depending on the country].
Facility-level variables examined included type of setting (urban, rural); type of facility (primary, secondary, tertiary, private); program size (i.e. number of patients active in HIV care, both in HIV care and on ART, in the quarter prior to each individual's date of enrollment); number of days/week of facility operation; and availability of VCT and PMTCT on site.
Contextual measures were created for each of the 15 subnational regions where one of the study facilities was located; they included HIV prevalence, HIV knowledge (mean score on five items assessing comprehensive HIV knowledge), testing coverage (percentage of population tested and received results within the past 12 months), stigma (mean score on four items indicating acceptance of HIV-positive people, reverse-coded), education (percentage of population having completed primary school), employment (percentage of population employed), and income distribution (percentage of households in the first quintile of the national wealth index).
Statistical analyses
We conducted two statistical analyses. The first assessed change over time in late enrollment in care and median CD4 þ cell count at enrollment, and included the 138 facilities that provided services from 2006 to 2011. For late enrollment, statistical significance tests were performed using a Poisson regression model with generalized estimating equations (GEEs), to account for clustering within facilities, treating calendar time as a continuous time measure. The models produced risk ratios for late enrollment per half year increase in calendar time. For median CD4 þ cell count at enrolment, we used the Kruskal-Wallis test for comparisons over time. To assess the effect of missing outcome data on estimates of change over time, we multiply imputed outcomes for those missing both CD4 þ cell count and WHO clinical stage at enrolment, and compared the findings to those observed with complete data.
The second analysis examined correlates of late enrollment in care in 2011 and included the 195 facilities providing services at that time. Relative risks of late enrollment in care were estimated using generalized linear models with a binomial distribution and a log link with GEE. Modeling was done in several steps. First, individual-level variables that were significantly associated with late enrollment in bivariate analyses were included in a multivariable model and retained if they were significant at P value less than 0.05. Second, the same was done for facility-level variables. Next, variables that were significant in each of these two multivariable models were combined into a two-level model and retained if they were significant. Fourth, as we did not have sufficient regions to assess the independent associations of contextual-level variables with late enrollment, each contextual-level variable was added to the two-level model and retained if statistically significant. Finally, nonsignificant correlates were dropped unless they altered other estimates by 10% or more. We conducted sensitivity analyses to determine if findings were altered if the definition of late enrollment was based on the 2006 WHO treatment guidelines (CD4 þ <200 cells/ml or WHO stage 4 or; if missing CD4 þ cell count, WHO stage 3 or; if pregnant or active TB, CD4 þ <350 cells/ml) [28] ; data for each country were removed; the analysis was restricted to the 138 facilities used in the time-trend analysis; and patients defined as enrolling late only on the basis of having initiated ART within 1 month of enrollment were removed.
Results
Study population and missing data
In the 138 facilities that reported data from 2006 to 2011, 307 100 HIV-positive newly enrolled adult patients had data on CD4 þ cell count and/or WHO stage. In 2006, 44 804 patients (83.5% of all newly enrolled adults) met these criteria; in 2011, the respective number was 39 725 (91.4%) ( count increased significantly from 242 cells/ml in 2006 to 292 cells/ml in 2011 (P trend < 0.0001), or 50 cells/ml in 6 years ( Fig. 2a) . A significant increase in median CD4 þ cell count was noted over the study years among nonpregnant and pregnant women, and men (P trend < 0.0001) ( Fig. 2a) , and in all countries (P trend < 0.0001) (Fig. 2b) . Considering the full distribution of CD4 þ cell count at enrollment including those missing (Fig. 3) , the proportion with CD4 þ at least 350 cells/ml increased from 19 to 24.8% of patients (with an increase from 10.8 to 14.5% among those with CD4 þ >500 cells/ml), and the proportion with CD4 þ below 200 cells/ml decreased from 23.4 to 21.6% (overall x 2 P < 0.0001).
Multilevel correlates of late enrollment in HIV care: 2011
In the 195 facilities that reported data in 2011, 46 201 newly enrolled adult patients had sufficient information to define whether they enrolled late in care (91% of all newly enrolled adults); of these, 55.6% enrolled late ( [29] , and this percentage increased to 57% by 2011 [30] .) In our study, between 2006 and 2011, the prevalence of late enrollment in HIV care decreased from 69.9 to 57.2%, and the median CD4 þ cell count at enrollment in care increased from 242 to 292 cells/ml. A decline in late enrollment was observed across all categories of patients and in all four countries, strengthening the conclusion that these results reflect actual changes and are not merely a consequence of shifts in the characteristics of the patient populations enrolling in these programs. The possibility remains that some portion of the decline in late enrollment into care that we observed is due to a relative increase in the number of healthier individuals who had outcome data in the latter years of this study. However, based on analyses examining characteristics of patients missing outcome data in 2006 and 2011 and on those with multiply imputed outcome data, we believe this attenuation, if present, is small.
Despite these encouraging findings, our analysis also showed that in 2011 -nearly a decade after HIV service scale-up began in sub-Saharan Africa -more than half of all individuals enrolled in care when they already were eligible for ART by 2010 WHO guidelines. Without a significant change in the observed rate of decrease in late enrollment in care -3% per year -more than another decade will pass before fewer than one-quarter of patients will enroll late according to those guidelines. Given that the median time from HIV infection to reaching a CD4 þ cell count below 350 cells/ml is approximately 4 years [31] , our study suggests that opportunities are missed to diagnose individuals earlier in disease, and underscores that greater efforts are needed to identify and link to care those with HIV infection prior to development of symptoms.
To further understand the factors associated with late enrollment in HIV care, we examined its correlates in 2011. More extensive HIV testing coverage in the areas surrounding the care facility was associated with a lower risk of late enrollment, even controlling for HIV prevalence, suggesting that expanded testing could lead to earlier enrollment in care. Community-based testing campaigns [32] and home-based counseling and testing [33] are important to pursue, although linkage to care after a positive HIV test may be a challenge with these approaches [33] [34] [35] . Research urgently needs to continue to explore these and other approaches to increase early diagnosis and prompt linkage to care.
Of the facility characteristics examined, only larger program size, in terms of number of active patients, was associated with a small increase in risk of late enrollment. This could reflect greater travel distance from outlying areas to a large central clinic or scheduling constraints at large facilities. Individual characteristics were strong predictors of late enrollment, even accounting for facility and contextual factors. As observed in two other studies in sub-Saharan Africa [23, 36] , being male, unmarried, and of older age were characteristics significantly associated with late enrollment in HIV care in our study. Women typically have more contact with the healthcare system [37] , thus likely facilitating access to earlier HIV testing and engagement in HIV care, and this is especially true for pregnant women. Older people may be less likely to believe they are at risk for HIV, potentially resulting in delayed testing [23] . Being married or living with a partner may facilitate earlier enrollment, as having a partner known or suspected to be HIV-positive is a common motivation for HIV testing [38] and partner support may encourage prompt enrollment in HIV care [39] .
A patient's point of entry into HIV care also was an important correlate of late enrollment. Individuals who were diagnosed through VCT or in a PITC setting were 2436 AIDS 2014, Vol 28 No 16 significantly more likely to enroll late, whereas individuals who entered care through PMTCT sites were less likely to do so, even accounting for sex and pregnancy status, probably reflecting the fact that all PMTCT clients are routinely offered HIV testing. Therefore, although costly, a policy of screening rather than testing based on symptoms or the presence of risk factors might reduce the proportion of individuals who enroll late in care.
The study had a number of strengths including the large number of patients from diverse sites across sub-Saharan Africa, use of data from routine clinical care, 6 years of data from the same facilities, which permitted analysis of trends over time unconfounded by changes in the number of facilities included each year, and the inclusion of facility and contextual correlates of late enrollment in addition to individual characteristics. A limitation was that CD4 þ cell count data at enrollment were missing for 40-45% of individuals and, other than excluding those who transferred from another site, we were unable to exclude those who may have 'newly enrolled' more than once. Furthermore, we had limited power to detect associations with contextual-level factors with only 15 subnational regions.
In conclusion, we observed a substantial decrease in the proportion of patients enrolled in HIV care at advanced stages of HIV disease between 2006 and 2011 in 138 facilities across four sub-Saharan African countries. Despite this progress, the decline in late enrollment was slow, and 57% of patients in 2011 enrolled in care at thresholds below WHO 2010 ART treatment guidelines. Although the expansion of testing, care, and treatment has resulted in significant improvements in outcomes for HIV-positive individuals, substantial efforts are needed to ensure that further gains are achieved. Encouragingly, we found that several of the correlates of late enrollment in 2011 reflect modifiable factors. That people entering care via PMTCT and those living in regions with higher HIV testing coverage have lower risk of late enrollment underscores the importance of continuing to scale up testing in order to identify individuals earlier in disease. Innovative approaches to increase testing uptake prior to symptom development may be the most rapid way to reduce late enrollment in care.
